IDEAS home Printed from https://ideas.repec.org/a/eee/teinso/v68y2022ics0160791x21003249.html
   My bibliography  Save this article

Biopharmaceutical patent protection vs. generic drug competition: Traversing the public policy tightrope

Author

Listed:
  • Hemphill, Thomas A.

Abstract

The Support Technology & Research for Our Nation's Growth and Economic Resilience (STRONGER) Patents Act, introduced in the 115th Congress, focuses on inter partes review (IPR) and post-grant review (PGR) proceedings that challenge patent validity at the U.S. Patent and Trademark Office, Patent Trial and Appeals Board (PTAB). Quinn, Brachmann, Malone, and Morinville (2018) evaluated patent data for the PTAB covering the first five plus years (through 2017) of the PTAB's operations, and calculate an 82.5% defect rate, i.e., where at least one patent claim is determined invalid and thus the invention not patentable. This finding could signal serious problems either with patent examination quality at the USPTO or with an aggressive PTAB. For recommended future research, further analysis of more recent (2018–21) patent-related validity data should be undertaken, as well as investigating the impact of the recently enacted CREATES Act on the relative strength of biopharmaceutical patent protection.

Suggested Citation

  • Hemphill, Thomas A., 2022. "Biopharmaceutical patent protection vs. generic drug competition: Traversing the public policy tightrope," Technology in Society, Elsevier, vol. 68(C).
    • Handle: RePEc:eee:teinso:v:68:y:2022:i:c:s0160791x21003249
    DOI: 10.1016/j.techsoc.2021.101849
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0160791X21003249
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.techsoc.2021.101849?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:teinso:v:68:y:2022:i:c:s0160791x21003249. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: https://www.journals.elsevier.com/technology-in-society .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.